In some severe cases anti-inflammatory medications, such as corticosteroids are needed to suppress inflammation until the infection has been eliminated.

In much higher doses, glucocorticoids are used to suppress various allergy, inflammation, and autoimmune disorders.

The goal of IBD treatment is to suppress inflammation.

The ability of these extracts to suppress inflammation was first described in the early 1960s.

They suppress inflammation as well as bacteria.

Treatments also include drying and peeling agents or oral antibiotics that suppress bacteria and inflammation.

In addition, researchers observed that palmitoleate suppresses inflammation, which is considered by many to be a primary factor leading to metabolic disease.

An example is the ability of pharmacologic doses of glucocorticoids to suppress inflammation.

It suppresses inflammation in a similar way to steroids, and is equally as effective as a mid-potency steroid.

These data taken together suggest that TGF-β1 is able to stimulate fibrogenesis and to suppress inflammation.